Navigation Links
American Academy of Dermatology: New Study Finds Women More Likely Than Men to be Affected by Acne as Adults
Date:10/18/2007

had ever had a pimple or acne, the vast majority (73.3 percent) of participants responded that at one time or another they had dealt with acne. The majority also reported that they had experienced acne as teenagers, with the number of men and women affected by the condition nearly identical (68.5 percent of male participants and 66.8 percent of female participants).

Interestingly, the survey found that for every age group following the teenage group, the reported incidence of acne was significantly higher among women than men. Specifically,

-- During their 20s, 50.9 percent of women and 42.5 percent of men

reported experiencing acne.

-- During their 30s, 35.2 percent of women and 20.1 percent of men

reported experiencing acne.

-- During their 40s, 26.3 percent of women and 12 percent of men reported

experiencing acne.

-- During their 50s or older, 15.3 percent of women and 7.3 percent of men

reported experiencing acne.

A separate section of the survey, which included questions assessing aspects of acne specific to women, asked female participants to note changes in acne around the time of their menstrual period, their pre-menopausal or post-menopausal status, and the effect of any treatments for symptoms of menopause on acne. Of the pre-menopausal women surveyed, 62.2 percent noted that their acne gets worse around the time of menstruation. In addition, of the 86 women who reported using either hormone replacement therapy or over-the-counter medications for the side effects of menopause, nine women (10.5 percent) reported improvement in their acne with the use of these therapies. However, 75 of the women (87.2 percent) reported no change with these menopausal therapies, and two women (2.3 percent) reported that their acne symptoms worsened.

"Our findings demonstrate that acne is a persistent problem for people of all ages, but clearly women seem to be affected by this medical condition mo
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Abstain from sex- the latest mantra of American teens
2. Clintons new problem - Is the outgoing American president suffering from skin cancer?
3. American scientists alter gene makeup of babies
4. FDA attacks American Red Cross for blood violations
5. Poll Finds Many Americans Misinformed About Cancer
6. Poll Finds Many Americans Misinformed About Cancer
7. Hypertension Drug of Choice for African Americans
8. 38 million Americans including 14 million children left to combat hunger
9. Americans Consume Far Too Much Salt and Sodium
10. Americans Growing Out Of Shape
11. Rise in Stress among Americans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)...ombining natural organic atoms with metal complexe...ed a new type of enzyme inhibitor capable of block... cancer development. , Based on studies in huma...eveloping new ways to treat cancer by dampening th...olled tumor growth. , Details of the study, to b...
(Date:5/15/2008)...ay 15 /PRNewswire-FirstCall/ -- Lung cancer patien...sions may fare better as a,result, according to da...C),clinical trial. Data from the trial, which invo... for injection), will be presented at the 44th Ann...cology (ASCO) in Chicago,Ill., May 30 -- June 3, ...
(Date:5/15/2008)...ity-control audit of community hospitals associate...gests that a partnership between a major academic ...are created, and community hospitals, where most c...uickly and effectively disseminating advances in c...d Comprehensive Cancer Center in Philadelphia, fir...
(Date:5/15/2008)...motherapy given in conjunction with cancer vaccine...ly improving the effectiveness of this promising t...earchers in the Duke Comprehensive Cancer Center. ...ls that suppress immune function and we speculated...used in conjunction with vaccines, which work by b...
Breaking Medicine News(10 mins):Health News:Novel enzyme inhibitor paves way for new cancer drug 2Health News:Novel enzyme inhibitor paves way for new cancer drug 3Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 2Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 3Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 4Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 5Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 6Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 7Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 2Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 3Health News:Chemotherapy might help cancer vaccines work 2
... Agreement with Laboratoire Physcience, France, fo...ibra(R)//, as a single dose mini-shot, in France, ...ssfully launched its Slim 10/10 product into these... successful ever product launch into the French ma...
...ering from symptoms of hypertension in the young d...consequences// of hypertension as they become adul... and found that prehypertension leads to hypertens...alkner, MD, professor of medicine and pediatrics a...
...lled antisense drugs, which can block the genes as...til now, it has been difficult for scientists to f...vented from breaking down before they reach the ta...e overcome by combining the drugs with small gold ...
...r more drugs made by a Heilongjiang Province drug ...ed with a poisonous industrial chemical. // It w...cal hospital in Guangzhou, capital city of south's... have shown symptoms of acute renal failure after ...
Other Medicine News:Health News:Prehypertension in the Young Leads to Hypertensive Adults 2Health News:Anti-Sense Drugs and Nanotechnology Offer New Hope In Cancer Fight 2Health News:Investigators Find Poisonous Chemicals In Four More Drugs In China 2
(Date:5/15/2008)... GREEN BAY, Wis., May 15 /- Omeg... be further considered as a credible natural,alter...ty in ADHD patients,recent in vivo French study r...cial effects of omega-3 in hyperactivity, French r...ld have specific positive effects on,impulse contr...
(Date:5/14/2008)... CAMBRIDGE, Mass., May 14 /PRNewswire-FirstCa...announced that the results from its Phase II coron... the peer-reviewed,EuroIntervention Journal. The p...te haemoglobin based oxygen therapeutics in electi...ale, protocol design, and haemodynamic,results." T...
(Date:5/14/2008)... Believed by experts to be important for cer...RNewswire-FirstCall/ -- New data from an,extended ...GSK ) cervical,cancer candidate vaccine, CERVARIX(... antibodies against the two most common cervical c... 6.4 years. This is the longest,duration of sustai...
(Date:5/14/2008)... Data Presented at the American Society of Hyp...ual Scientific Meeting - A cumulative forty-fiv...nsion treated with a regimen of BENICAR(R) (olmesa...medoxomil/hydrochlorothiazide) achieved ... Eight out of 10 (cumulative 81%) patients with st...
Breaking Medicine Technology:Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 3Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial 2Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial 3CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 2CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 3CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 4CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 5CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 6New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 2New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 3New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 4New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 5New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 6New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 7Weill Cornell science briefs May 2008 19346 1Weill Cornell science briefs May 2008 19346 2Weill Cornell science briefs May 2008 19346 3Weill Cornell science briefs May 2008 19346 4Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly 2443 Million 19344 1Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly 2443 Million 19344 2Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly 2443 Million 19344 3Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly 2443 Million 19344 4Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly 2443 Million 19344 5Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly 2443 Million 19344 6Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly 2443 Million 19344 7Kresge Foundation Employs New Funding Methods in its First Quarter Grant Awards of Nearly 2443 Million 19344 8Saia Partners with Susan G Komen for the Cure 19339 1Saia Partners with Susan G Komen for the Cure 19339 2Saia Partners with Susan G Komen for the Cure 19339 3Milliman Says 2008 Medical Cost for American Family of Four Exceeds 2415 600 19334 1Milliman Says 2008 Medical Cost for American Family of Four Exceeds 2415 600 19334 2
...GE, Mass.--(BUSINESS WIRE)--Jun 6, 2007 - Combinat...that data from its,randomized, blinded, placebo-co...ients with osteoarthritis (OA) and rheumatoid,arth... against,Rheumatism (EULAR) Annual Congress of Rhe...Spain., Schedule of Events: , -- Satellite Symposi...
...33 reduces esophageal reflux - , Waltham, Mass., J...reported positive results of its randomized, doubl...33 for gastroesophageal,reflux disease (GERD). Th...pt for DDP733 as a treatment for nocturnal GERD,(N...tical,significance over placebo on the primary end...
Other Medicine Technology:Novel Mechanism Insights and Additional Data on CombinatoRx Drug,Candidates to Be Presented at Upcoming EULAR Meeting 2Novel Mechanism Insights and Additional Data on CombinatoRx Drug,Candidates to Be Presented at Upcoming EULAR Meeting 3Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 2Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 3
Lyphochek Urine Bone Markers Control is a bilevel human urine based control designed to monitor tests for urinary markers of osteoporosis management and bone resorption.
Lyphochek Tumor Marker Control is a comprehensive, bilevel product designed to assess the performance of various cancer antigen tests, including esoteric tumor markers.
Lyphochek Maternal Serum Control is a trilevel product with analytes at clinically significant levels to monitor maternal serum analysis.
Lyphochek Immunoassay Plus Control provides the clinical laboratory with the most comprehensive control in the world for monitoring immunoassay and therapeutic drug monitoring procedures, eliminating
Medicine Products: